Posts in tag
Walter and Eliza Hall Institute
New drug in leukaemia fight
A new anti-cancer medication has been approved by the TGA for treatment of the most common type of leukaemia in Australia Venclexta (venetoclax) is a once-daily oral B-cell lymphoma-2 inhibitor …